Dendreon (DNDN) Higher On Amgen (AMGN) Takeover Rumor
Tweet
Share
E-mail
Get Alerts DNDN Hot Sheet
Join SI Premium – FREE
Dendreon (Nasdaq: DNDN) is seeing sharp upside action Tuesday on renewed rumors Amgen Inc. (Nasdaq: AMGN) could make a move to acquire the company.
While Dendreon has been mentioned as a clear takeover target in the biotech space, today's rumors appear to be coming from unreliable sources and nothing appears imminent.
Shares of DNDN are up 6.5 percent midday to $14.07.
While Dendreon has been mentioned as a clear takeover target in the biotech space, today's rumors appear to be coming from unreliable sources and nothing appears imminent.
Shares of DNDN are up 6.5 percent midday to $14.07.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Paramount stock surges on report Sony, Apollo are considering joint bid
- Ericsson (ERIC) to Cut 240 Employees in China - WSJ
- Bentley Systems Inc. (BSY) is Exploring Options That Include A Sale After Attracting Interest From Potential Suitors, Sources Say - Reuters
Create E-mail Alert Related Categories
RumorsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
